
By Davit Kirakosyan
Here is your Pro Recap of the biggest analyst cuts you may have missed since Friday: a Reduce initiation at Snap, and downgrades at Carlisle, Olin, Somalogic, and Nordson.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
HSBC initiated coverage on Snap (NYSE:SNAP) with a Reduce rating and a price target of $7.50. As a result, shares fell more than 1% pre-market today.
The bank stated that due to the increasing gulf in content, user engagement, advertising solutions, and financial resources between Snap and other leading social media platforms, a successful turnaround of Snap's core advertising business is unlikely.
Jefferies downgraded Carlisle Companies (NYSE:CSL) to Hold from Buy and cut its price target to $290.00 from $325.00, as reported in real-time on InvestingPro.
Wells Fargo downgraded Olin (NYSE:OLN) to Equal Weight from Overweight and cut its price target to $50.00 from $65.00. Shares fell more than 1% pre-market today.
Canaccord Genuity downgraded Somalogic (NASDAQ:SLGC) to Hold from Buy and cut its price target to $2.50 from $5.00.
Given the recent inconsistent financial performance, transitional nature of the company's leadership team and competitive headwinds from companies such as Olink, we maintain a reduced level of conviction in SomaLogic's ability to penetrate its market opportunity in the near term. Thus, we believe the shares offer limited upside potential in the next 12 months.
Nordson (NASDAQ:NDSN) shares fell more than 1% pre-market today after Jefferies downgraded the company to Hold from Buy and cut its price target to $240.00 from $260.00.
Amid whipsaw markets and a slew of critical headlines, seize on the right timing to protect your profits: Always be the first to know with InvestingPro.
Start your free 7-day trial now.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.